All Episodes
Rx for Biotech — 87 episodes
Part 1: The Radiopharmaceutical Launch Playbook: What Pharma Must Get Right Beyond the Drug
Why Fertility Care Needs to Change - And How Technology Can Help
The Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic
What If Your Own Cells Could Cure Cancer? CAR-T Therapy Explained
The Future of Brain Cancer Care: Combining Diagnostics and Targeted Radiation Therapy
How Targeted Chemotherapy and Immunotherapy are Changing Cancer Care
The Future of Precision Medicine: How Biomarkers Can Guide Your Treatment
How Novartis is Changing Cancer Treatment and Putting Patients First in Modern Cancer Care
Fixing the Body's Shield: A New Way to Fight Neurodegenerative Diseases
How to Advocate for Yourself in Cancer Care: Insights from a Top Oncologist
A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy
Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control
How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases
Restoring Breath: Biologic Innovation for the Most Vulenerable Patients
Reprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy
The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies
Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer
How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly
Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt
How AI is Transforming Job Search and Recruiting in Life Sciences and Technology
From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere
The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc
From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi
How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD
The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024
How NGGT is Pioneering the Next Wave of Gene Therapies
Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
Left Behind: Addressing Health Equity for the Rare Disease Patient Community
Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
Unlocking AI In Oncology with James Zou, PhD
Revolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan
Building a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine
How MedStack helps Health Tech companies with Compliance and Data Privacy
How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System
ASCO 2024 Recap, ADCs, Cell Therapies and RLTs
ASGCT 2024 Abstracts Preview
Update on Evolving Tech and Data Standards to Improve Cell Therapy Informatics
How Ryght is Building a Generative AI Platform for BioPharma
Revolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar
ASGCT Annual Meeting Preview
2024 Biopharma Investment Outlook with Chris Dokomajilar
How one Survivor beat the odds against Mucosal Melanoma
Mark Carbone on How Respiratory Muscle Training can improve Cardiopulmonary Outcomes
Episode 2: Future Advances in Cell Therapy Analytics
Episode 1: Current Advancements in Cell Therapy Analytics
Health Policy Update: IRA, 340b Drug Pricing and PBMs
Special Episode: ASGCT Policy Summit Highlights
The IRA 1-year Anniversary Episode: What Lies Ahead?
Developing Best-in-Class Radiopharmaceuticals for Cancer Patients
ASGCT Policy Summit Preview
How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes
How Medicenna is Developing "Superkines" as Novel Immunotherapies
How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing
Novel Immunotherapy approaches to engaging the Innate Immune System
Emerging Therapies for Rare Genetic Mitochondrial Diseases
Harnessing the Cell Cycle to Treat Cancer and other Serious Diseases
American Society of Gene and Cell Therapy Meeting Highlights
Emerging PSMA Targeted Radioantibody Therapies for Prostate Cancer with CEO, Philip Kantoff, MD
Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron
Erandi De Silva, PhD on Building a Gene Therapy Pipeline and Culture
Gene Therapy Landscape Trends: An Interview with Forge Biologics CEO, Tim Miller, PhD
AACR 2023 Preview
New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD
FDA AMAT for Regenerative Medicine Therapies Workshop Recap
Don Davis, PhD, MBA on Challenges in Scaling Life Science Companies
Applications of AI and Machine Learning in BioPharma and Healthcare
A Look Ahead to 2023 Biopharma M&A, Venture Financing, Licensing and Partnerships
Biopharma Products and Companies to Watch in 2023
American Society of Hematology Highlights
Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows
How to Improve Customer Engagement in 2023
Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah
Meeting on the Mesa Roundtable Part 2: Applying "A-Cell" Concepts when Developing Cell Therapies
Meeting on the Mesa Roundtable Part 1: 'A-Cell' Principles of Quality by Design
IRA Impact on Biopharma Drug Development
OTAT Townhall Insights for Developers of Gene Therapies
Insights into the Cell and Gene Therapy Landscape
Medical Communications after the Pandemic
Best Practices in Market Access, Trade and Distribution
Chandra Ramanathan, PhD on How to Create Value through Innovation Ecosystems
Chris Dokomajilar on Trends in Life Science Investing, M&A and Partnering
CRISPR and Gene Editing for Human Disease
The Future of Cell and Gene Therapies
Regulatory Challenges in Biotech